There are 1076 resources available
668P - The Impact of MTAP loss on response to immune checkpoint inhibitors in stage IV NSCLC: A prospective real-world analysis
Presenter: Aya El-Helali
Session: Poster Display session
Resources:
Abstract
669P - A retrospective observational study on the efficacy of local ablative therapy for oligoprogression in non-small cell lung cancer patients who responded to immunotherapy combined chemotherapy
Presenter: Shoichi Kuyama
Session: Poster Display session
Resources:
Abstract
670P - Phase III study of zipalertinib plus first-line (1L) platinum-based chemotherapy in patients (pts) with non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion (ex20ins) mutations (REZILIENT3): Safety lead-in results
Presenter: Takayasu Kurata
Session: Poster Display session
Resources:
Abstract
671P - Radiomics models using machine learning algorithms to differentiate the primary focus of brain metastasis
Presenter: Yuping Xie
Session: Poster Display session
Resources:
Abstract
672P - Association between the administration time and therapeutic effect of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study
Presenter: Yuki Iwahashi
Session: Poster Display session
Resources:
Abstract
673P - Diagnosis and treatment of ROS1 fusion-positive non-small-cell lung cancer in China: Preliminary report of a nationwide survey
Presenter: Fei Zhou
Session: Poster Display session
Resources:
Abstract
674P - Real-world outcomes of first-line platinum doublet chemotherapy plus Tyrosine Kinase Inhibitors (TKI) in advanced epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC)
Presenter: Yi Fen Low
Session: Poster Display session
Resources:
Abstract
675P - Assessing later-line treatment strategies and outcomes in EGFR oncogene-driven stage IV non-small cell lung cancer
Presenter: Meghana Maddula
Session: Poster Display session
Resources:
Abstract
676P - NEJ053C: A phase II study of nivolumab and ipilimumab combined with chemotherapy after lung stereotactic body radiotherapy as first-line therapy for stage IV non-small cell lung cancer
Presenter: Kageaki Watanabe
Session: Poster Display session
Resources:
Abstract
677P - Comparison of performance of MET amplification detection by FISH, NGS and ddPCR in EGFRm advanced NSCLC patients post first-line osimertinib treatment failure: Analysis from a prospective, multi-center study in China
Presenter: Puyuan Xing
Session: Poster Display session
Resources:
Abstract